Tech Companies to Watch

Natural State Research, Inc.

Natural State Research, Inc. (NSR), a research and development company has the solution at our disposal. NSR has developed a unique technology (patent pending and award winning) to dispose of any type of waste plastics by converting it into a liquid fuel. This process can produce approximately 1200-1300 ml of NSR fuel from one kilogram of waste plastic. The fuel production process yields is about 95% and the other 5% is solid reside. The exact yield depends on the type of plastic, and the grade of NSR fuel desired. The technology is environmentally friendly. As per preliminary tests the produced fuel burns efficiently and relatively clean and it would be produced at a lower overall cost.

Based on the available statistics, USA alone generates 48 million tons of waste plastic annually. Using this technology, these vast amounts of waste plastics can be converted to staggering 16,128–18,144 Billion gallons of NSR fuel. NSR fuels are similar to gasoline, diesel, aviation, jet fuel, home heating oil and fuel oil. It can efficiently power any generators, cars, trucks, airplanes, fuel power plant and other internal combustion engines. Research indicates that probably it is not necessary to retrofit the engines for NSR use in order to have maximum efficiency.1 gallon of NSR Fuel can produce 36-40 kWh of electricity.

NSR has demonstrated the feasibility of producing electricity from its fuel. The production process is simple and inexpensive, and it will provide fuel at a cost that is more attractive than gasoline. Once the fuel production process is automated and efficiencies in the production are obtained, the produced fuel should have a retail price that would be lower and more stable than conventional fuels such as commercially available gasoline and diesel.

Natural State Research, Inc.

Stamford, CT

President & CEO: Karin Kaufman

www.natrualstateresearch.com

IContain

We've created Onstar for Appliances. We can lock down and locate electronics for the rent-to-own industry. It's a 8 billion dollar a year business that has 2% loss a year.  We are the only product that does what we can do.

IContain

Columbia, CT

CEO: Todd Kleperis

www.i-contain.com

TicketNetwork, Inc.

TicketNetwork was founded in 2002 as a software company, developing the pathways needed to create our massive online marketplace. We have thousands of sellers offering 7,500,000 tickets every day, including fans with extra tickets to sell and licensed ticket brokers. Our purpose is simple: provide a huge selection of quality seats to events, even when they are sold out elsewhere.

TicketNetwork, Inc. was chosen as one of the 2010 Marcum Tech Top 40 companies.

TicketNetwork, Inc.

Vernon, CT

CEO: Donald Vaccaro

www.ticketnetwork.com

Planitretail, LLC

Targeted media planning and buying for retailers supported by advanced customer analytics using internal proprietary software.  Recently won the national Radio Shack account responsible for managing and optimizing a $50MM print advertising program for 5000 store locations nationwide.  Core capabilities are sophisticated planning, buying, analytics and local media targeting targeting.

   

Planitretail, LLC

Windsor, CT

President & CEO: Matt Spahn

www.planitretail.net

TBIG, Inc

TBIG, Inc. is an early stage biotech company that holds the assignment for twelve patent applications, eight of which have issued – one in 2008 and seven during the past year.  This U.S. patent portfolio represents platform technology that will generate new patents for different clinical applications (i.e., risk assessment, screening, diagnosis, prognosis, theragnosis, as well as disease recurrence monitoring and treatment) in different diseases (e.g., cancer, arthritis, and certain neuropathies) for years to come.  The initial focus of TBIG, Inc. is to develop this technology for cancer ‘theragnostics.’  That is, the same disruptive technology can be used to both treat cancer and to predict and monitor therapeutic responsiveness to biological agents that target the epidermal growth factor receptor (EGFR/HER) family of genes and proteins.  TBIG, Inc. and its prospective business partners will be the first to market an entirely new class of cancer biotherapeutic – a coupled diagnostic/therapeutic (i.e., theragnostic) that can be used to manage cancer patients across disease sites.  The issuance of these patents marks the beginning of a new phase of development for this young company, and three innovative business models are being considered to bring the cancer theragnostic component of this technology to market:  1) a niche $25-40 million business, targeting the management of a few strategic malignancies, 2) a $250 million business replacing most of the more costly tissue/tumor-based cancer diagnostic tests, saving insurance insurers $500 million a year, or 3) a $1.0 billion gatekeeper for the management of personalized medicines that target the EGFR/HER gene family.

TBIG, Inc

New Haven, CT

Nita Maihle

Innovatient Solutions

The patient experience begins the minute a patient walks through the doors.  Innovatient Solutions has developed the Patient Centered Information System, PCIS, to provide the quality care management tools for the care team to dramatically improve the patient experience.

PCIS delivers a solution to provide a complete, intuitive approach to patient engagement.  Our inviting approach to promoting educational material, entertainment, and hospital services provides the patient with the confidence and information necessary to make the most critical decisions during their stay.  PCIS will reduce the expenses of the hospital by improving care team efficiencies and grow revenues through improved HCAHPS and CMS Quality Indicator scores and by opening new revenue streams.

Innovatient Solutions

West Hartford, CT

CEO: Jolina Lambert

www.innovatient.com

Terra Technology

Terra Technology is the most-trusted provider of innovative supply chain solutions for consumer products companies. Terra Technology’s solutions use better mathematics and downstream data like POS to improve supply chain performance, reducing forecast error up to 50% and inventory up to 20%. More accurate forecasts save money, lower inventory, improve customer service and decrease waste. Some of the world’s largest consumer packaged goods companies use Terra Technology, including Procter & Gamble, Unilever, Kraft Foods, Kimberly-Clark, ConAgra Foods and Campbell Soup.

Terra Technology was chosen as one of the 2010 Marcum Tech Top 40 companies.

Terra Technology

Norwalk, CT

President & CEO: Robert Byrne

www.terratechnology.com

Soft Tissue Regeneration

Soft Tissue Regeneration, Inc. (“STR”) has developed and preliminarily tested a potential breakthrough technology for soft tissue regeneration of the anterior cruciate ligament (“ACL”) of the knee. This patented and proprietary technology, using an FDA-approved polymer called polyL-lactide (PLLA), already widely used in biomedical devices, could allow STR to address a tremendous unmet need in the repair of musculoskeletal soft tissue injuries of the knee. The product is called the L-C Ligament™ for ACL reconstruction. It is a synthetic scaffold that stabilizes the knee and encourages the regeneration of ligament tissue and should result in faster, better healing and greater odds of making a full recovery. STR was founded based on technologies developed by Cato T. Laurencin, M.D., Ph.D.

Soft Tissue Regeneration

New Haven, CT

President: Joseph Reilly

www.softtissueregeneration.com

Soft Tissue Regeneration

Soft Tissue Regeneration, Inc. (“STR”) has developed and preliminarily tested a potential breakthrough technology for soft tissue regeneration of the anterior cruciate ligament (“ACL”) of the knee. This patented and proprietary technology, using an FDA-approved polymer called polyL-lactide (PLLA), already widely used in biomedical devices, could allow STR to address a tremendous unmet need in the repair of musculoskeletal soft tissue injuries of the knee. The product is called the L-C Ligament™ for ACL reconstruction. It is a synthetic scaffold that stabilizes the knee and encourages the regeneration of ligament tissue and should result in faster, better healing and greater odds of making a full recovery. STR was founded based on technologies developed by Cato T. Laurencin, M.D., Ph.D.

Soft Tissue Regeneration

New Haven, CT

President: Joseph Reilly

www.softtissueregeneration.com

Tangoe, Inc.

Tangoe’s vision is to provide clients with technology-driven professional expertise that allows them to more effectively acquire, control, understand, and manage their fixed and mobile communications services -- and their associated costs. With a growing network of independent TEM outsourcers utilizing Tangoe’s CMP software, Tangoe’s ability to help companies better manage their voice, data, and wireless costs is independent of a company’s decision to out-source or in-source their telecommunications expense management operations.

Tangoe, Inc. was chosen as one of the 2010 Marcum Tech Top 40 companies.

Tangoe, Inc.

Orange, CT

President, Founder, & CEO: Albert Subbloie

www.tangoe.com